MedTrace Logo

Visual Quality and Performance of Eyes With Asqelio™ EDoF Toric Lenses

NCT06707545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-08-27

No results posted yet for this study

Summary

This study evaluates the optical quality and clinical performance of the Asqelio™ EDOF Toric intraocular lens (IOL) in patients undergoing cataract surgery or refractive lensectomy. The Asqelio™ EDOF Toric IOL aims to provide improved vision at various distances and correct astigmatism compared to monofocal IOLs. Postoperative outcomes, including visual clarity, refractive correction, and patient satisfaction, will be assessed three months after surgery.

Conditions

  • Cataract
  • Presbyopia Correction

Sponsors & Collaborators

  • AST Products, Inc.

    lead INDUSTRY

Principal Investigators

  • Antonio Cano, MD, PhD · Hospital La Arruzafa

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-11
Primary Completion
2024-05-14
Completion
2024-05-14

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06707545 on ClinicalTrials.gov